M C Kraan
Overview
Explore the profile of M C Kraan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
1215
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Safy M, de Hair M, Jacobs J, Buttgereit F, Kraan M, van Laar J
PLoS One
. 2017 Dec;
12(12):e0188810.
PMID: 29267302
Background: Long-term treatment with glucocorticoids (GCs) plays an important role in the management of arthritis patients, although the efficacy/safety balance is unfavorable. Alternatives with less (severe) adverse effects but with...
2.
Emery P, McInnes I, Vollenhoven R, Kraan M
Rheumatology (Oxford)
. 2007 Dec;
47(4):392-8.
PMID: 18094000
Inflammation is the major factor driving the progression of structural damage in rheumatoid arthritis (RA); therefore, it is critical to achieve rapid suppression of inflammation to maximize disease control. The...
3.
Wijbrandts C, Dijkgraaf M, Kraan M, Vinkenoog M, Smeets T, Dinant H, et al.
Ann Rheum Dis
. 2007 Dec;
67(8):1139-44.
PMID: 18055470
Objective: To determine whether the heterogeneous clinical response to tumour necrosis factor (TNF)alpha blocking therapy in rheumatoid arthritis (RA) can be predicted by TNFalpha expression in the synovium before initiation...
4.
Tchetverikov I, Kraan M, van El B, Hanemaaijer R, Degroot J, Huizinga T
Ann Rheum Dis
. 2007 Sep;
67(1):128-30.
PMID: 17875551
Objective: To analyse the effects of leflunomide and methotrexate treatment on matrix metalloproteinase (MMP) activity levels in alpha2 macroglobulin/MMP (alpha2M/MMP) complexes in the systemic circulation of rheumatoid arthritis (RA) patients....
5.
Jahangier Z, Jacobs J, Kraan M, Wenting M, Smeets T, Bijlsma J, et al.
Ann Rheum Dis
. 2006 Apr;
65(10):1286-92.
PMID: 16627543
Objective: To explore whether pretreatment features of synovial tissue in patients with gonarthritis could predict the clinical effect of radiation synovectomy with yttrium-90 (90Y) and glucocorticoids or with intra-articular glucocorticoids...
6.
Haringman J, Gerlag D, Zwinderman A, Smeets T, Kraan M, Baeten D, et al.
Ann Rheum Dis
. 2004 Dec;
64(6):834-8.
PMID: 15576415
Background: Previous work identified synovial sublining macrophage numbers as a potential biomarker for clinical efficacy in rheumatoid arthritis. Objective: To investigate the association between changes in infiltration of synovial macrophages...
7.
Kroot E, Kraan M, Smeets T, Maas M, Tak P, Wouters J
Ann Rheum Dis
. 2004 Aug;
64(3):497-9.
PMID: 15297283
Background: Pigmented villonodular synovitis (PVNS) is considered to be a neoplastic-like disorder of the synovium histologically characterised by villonodular hyperplasia, resulting in dense fibrosis and haemosiderin deposition. The pathogenesis of...
8.
Goedkoop A, Kraan M, Teunissen M, Picavet D, de Rie M, Bos J, et al.
Ann Rheum Dis
. 2004 Jun;
63(7):769-73.
PMID: 15194570
Background: Tumour necrosis factor alpha (TNFalpha) blockade using infliximab, a chimeric anti-TNFalpha antibody, is an effective treatment for both psoriasis and psoriatic arthritis (PsA). Objective: To analyse the early effects...
9.
Kraan M, Smeets T, van Loon M, Breedveld F, Dijkmans B, Tak P
Ann Rheum Dis
. 2004 Apr;
63(9):1056-61.
PMID: 15115713
Background: T cells have a pivotal role in RA. Leflunomide inhibits pyrimidine biosynthesis, to which T cells are especially susceptible, and therefore may have a different cytokine profile than methotrexate....
10.
Kraan M, Haringman J, Weedon H, Barg E, Smith M, Ahern M, et al.
Ann Rheum Dis
. 2004 Apr;
63(5):483-8.
PMID: 15082476
Objective: To determine immunohistological markers in synovial tissue of patients with early rheumatoid arthritis (RA) which are associated with unfavourable disease outcome. Methods: Synovial tissue was obtained from 36 patients...